Growth potential Mid-sized clinical testing firm with revenue between 10M and 25M and a lean employee base suggests appetite for scalable services that improve lab throughput, efficiency, and payer mix optimization.

Digital footprint Active tech stack including AWS, analytics and marketing tools indicates openness to cloud-based lab management systems, cybersecurity enhancements, and data integration services to streamline operations.

Recent expansion Introduction of COVID-19 antibody testing in 2020 demonstrates willingness to expand service lines rapidly; opportunities exist to propose new molecular diagnostics, serology, or ancillary testing programs.

Competitive landscape Operates in a market with large health systems and diagnostics peers; position Piedmont as a partner for cost containment, faster turnaround times, and provider-network support to compete with bigger labs.

Sales focus Small to mid-size lab with strong growth signals may benefit from consultative services in business development, workflow optimization, and marketing automation to attract and retain customers.